カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の吸入＆点鼻薬ジェネリック医薬品市場2022年：コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他

◆英語タイトル：Global Inhalation and Nasal Spray Generic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8856 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：103 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

吸入＆点鼻薬ジェネリック医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の吸入＆点鼻薬ジェネリック医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

吸入＆点鼻薬ジェネリック医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他

用途別セグメントは次のように区分されます。
・喘息、COPD、アレルギー性鼻炎、その他

世界の吸入＆点鼻薬ジェネリック医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Teva、Sandoz (Novartis)、Mylan、Allergan、Cipla、Akorn、Apotex、Sun Pharma (Ranbaxy)、Nephron Pharma、Beximco Pharma、Hikma (Roxane)、XIANJU PHARMA

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、吸入＆点鼻薬ジェネリック医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な吸入＆点鼻薬ジェネリック医薬品メーカーの企業概要、2019年～2022年までの吸入＆点鼻薬ジェネリック医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な吸入＆点鼻薬ジェネリック医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別吸入＆点鼻薬ジェネリック医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの吸入＆点鼻薬ジェネリック医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での吸入＆点鼻薬ジェネリック医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および吸入＆点鼻薬ジェネリック医薬品の産業チェーンを掲載しています。
・第13、14、15章では、吸入＆点鼻薬ジェネリック医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Teva、Sandoz (Novartis)、Mylan、Allergan、Cipla、Akorn、Apotex、Sun Pharma (Ranbaxy)、Nephron Pharma、Beximco Pharma、Hikma (Roxane)、XIANJU PHARMA
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他
・用途別分析2017年-2028年：喘息、COPD、アレルギー性鼻炎、その他
・吸入＆点鼻薬ジェネリック医薬品の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・吸入＆点鼻薬ジェネリック医薬品のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・吸入＆点鼻薬ジェネリック医薬品のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・吸入＆点鼻薬ジェネリック医薬品の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・吸入＆点鼻薬ジェネリック医薬品の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Inhalation and Nasal Spray Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Inhalation and Nasal Spray Generic Drugs market size is estimated to be worth US$ 9067.6 million in 2021 and is forecast to a readjusted size of USD 13660 million by 2028 with a CAGR of 6.0% during review period. Asthma accounting for % of the Inhalation and Nasal Spray Generic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Corticosteroids segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Inhalation and Nasal Spray Generic Drugs include Teva, Sandoz (Novartis), Mylan, Allergan, and Cipla, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Inhalation and Nasal Spray Generic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Corticosteroids
Bronchodilators
Combinations
Decongestant Sprays
Others
Market segment by Application can be divided into
Asthma
COPD
Allergic Rhinitis
Others
The key market players for global Inhalation and Nasal Spray Generic Drugs market are listed below:
Teva
Sandoz (Novartis)
Mylan
Allergan
Cipla
Akorn
Apotex
Sun Pharma (Ranbaxy)
Nephron Pharma
Beximco Pharma
Hikma (Roxane)
XIANJU PHARMA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhalation and Nasal Spray Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhalation and Nasal Spray Generic Drugs, with price, sales, revenue and global market share of Inhalation and Nasal Spray Generic Drugs from 2019 to 2022.
Chapter 3, the Inhalation and Nasal Spray Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhalation and Nasal Spray Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Inhalation and Nasal Spray Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inhalation and Nasal Spray Generic Drugs.
Chapter 13, 14, and 15, to describe Inhalation and Nasal Spray Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Inhalation and Nasal Spray Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhalation and Nasal Spray Generic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Corticosteroids
1.2.3 Bronchodilators
1.2.4 Combinations
1.2.5 Decongestant Sprays
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhalation and Nasal Spray Generic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Asthma
1.3.3 COPD
1.3.4 Allergic Rhinitis
1.3.5 Others
1.4 Global Inhalation and Nasal Spray Generic Drugs Market Size & Forecast
1.4.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume (2017-2028)
1.4.3 Global Inhalation and Nasal Spray Generic Drugs Price (2017-2028)
1.5 Global Inhalation and Nasal Spray Generic Drugs Production Capacity Analysis
1.5.1 Global Inhalation and Nasal Spray Generic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Inhalation and Nasal Spray Generic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inhalation and Nasal Spray Generic Drugs Market Drivers
1.6.2 Inhalation and Nasal Spray Generic Drugs Market Restraints
1.6.3 Inhalation and Nasal Spray Generic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Inhalation and Nasal Spray Generic Drugs Product and Services
2.1.4 Teva Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sandoz (Novartis)
2.2.1 Sandoz (Novartis) Details
2.2.2 Sandoz (Novartis) Major Business
2.2.3 Sandoz (Novartis) Inhalation and Nasal Spray Generic Drugs Product and Services
2.2.4 Sandoz (Novartis) Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Inhalation and Nasal Spray Generic Drugs Product and Services
2.3.4 Mylan Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Inhalation and Nasal Spray Generic Drugs Product and Services
2.4.4 Allergan Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Inhalation and Nasal Spray Generic Drugs Product and Services
2.5.4 Cipla Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Akorn
2.6.1 Akorn Details
2.6.2 Akorn Major Business
2.6.3 Akorn Inhalation and Nasal Spray Generic Drugs Product and Services
2.6.4 Akorn Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex Inhalation and Nasal Spray Generic Drugs Product and Services
2.7.4 Apotex Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharma (Ranbaxy)
2.8.1 Sun Pharma (Ranbaxy) Details
2.8.2 Sun Pharma (Ranbaxy) Major Business
2.8.3 Sun Pharma (Ranbaxy) Inhalation and Nasal Spray Generic Drugs Product and Services
2.8.4 Sun Pharma (Ranbaxy) Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Nephron Pharma
2.9.1 Nephron Pharma Details
2.9.2 Nephron Pharma Major Business
2.9.3 Nephron Pharma Inhalation and Nasal Spray Generic Drugs Product and Services
2.9.4 Nephron Pharma Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Beximco Pharma
2.10.1 Beximco Pharma Details
2.10.2 Beximco Pharma Major Business
2.10.3 Beximco Pharma Inhalation and Nasal Spray Generic Drugs Product and Services
2.10.4 Beximco Pharma Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hikma (Roxane)
2.11.1 Hikma (Roxane) Details
2.11.2 Hikma (Roxane) Major Business
2.11.3 Hikma (Roxane) Inhalation and Nasal Spray Generic Drugs Product and Services
2.11.4 Hikma (Roxane) Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 XIANJU PHARMA
2.12.1 XIANJU PHARMA Details
2.12.2 XIANJU PHARMA Major Business
2.12.3 XIANJU PHARMA Inhalation and Nasal Spray Generic Drugs Product and Services
2.12.4 XIANJU PHARMA Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Inhalation and Nasal Spray Generic Drugs Breakdown Data by Manufacturer
3.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inhalation and Nasal Spray Generic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Inhalation and Nasal Spray Generic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Inhalation and Nasal Spray Generic Drugs Manufacturer Market Share in 2021
3.5 Global Inhalation and Nasal Spray Generic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inhalation and Nasal Spray Generic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inhalation and Nasal Spray Generic Drugs Market Size by Region
4.1.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2028)
4.2 North America Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.3 Europe Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.5 South America Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Type (2017-2028)
5.3 Global Inhalation and Nasal Spray Generic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Application (2017-2028)
6.3 Global Inhalation and Nasal Spray Generic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
7.2 North America Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
7.3 North America Inhalation and Nasal Spray Generic Drugs Market Size by Country
7.3.1 North America Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
8.2 Europe Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
8.3 Europe Inhalation and Nasal Spray Generic Drugs Market Size by Country
8.3.1 Europe Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Market Size by Region
9.3.1 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
10.2 South America Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
10.3 South America Inhalation and Nasal Spray Generic Drugs Market Size by Country
10.3.1 South America Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Market Size by Country
11.3.1 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Inhalation and Nasal Spray Generic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inhalation and Nasal Spray Generic Drugs
12.3 Inhalation and Nasal Spray Generic Drugs Production Process
12.4 Inhalation and Nasal Spray Generic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inhalation and Nasal Spray Generic Drugs Typical Distributors
13.3 Inhalation and Nasal Spray Generic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Inhalation and Nasal Spray Generic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Inhalation and Nasal Spray Generic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Inhalation and Nasal Spray Generic Drugs Product and Services
Table 6. Teva Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sandoz (Novartis) Basic Information, Manufacturing Base and Competitors
Table 8. Sandoz (Novartis) Major Business
Table 9. Sandoz (Novartis) Inhalation and Nasal Spray Generic Drugs Product and Services
Table 10. Sandoz (Novartis) Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Inhalation and Nasal Spray Generic Drugs Product and Services
Table 14. Mylan Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Inhalation and Nasal Spray Generic Drugs Product and Services
Table 18. Allergan Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cipla Basic Information, Manufacturing Base and Competitors
Table 20. Cipla Major Business
Table 21. Cipla Inhalation and Nasal Spray Generic Drugs Product and Services
Table 22. Cipla Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Akorn Basic Information, Manufacturing Base and Competitors
Table 24. Akorn Major Business
Table 25. Akorn Inhalation and Nasal Spray Generic Drugs Product and Services
Table 26. Akorn Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Apotex Basic Information, Manufacturing Base and Competitors
Table 28. Apotex Major Business
Table 29. Apotex Inhalation and Nasal Spray Generic Drugs Product and Services
Table 30. Apotex Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sun Pharma (Ranbaxy) Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharma (Ranbaxy) Major Business
Table 33. Sun Pharma (Ranbaxy) Inhalation and Nasal Spray Generic Drugs Product and Services
Table 34. Sun Pharma (Ranbaxy) Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Nephron Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Nephron Pharma Major Business
Table 37. Nephron Pharma Inhalation and Nasal Spray Generic Drugs Product and Services
Table 38. Nephron Pharma Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Beximco Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Beximco Pharma Major Business
Table 41. Beximco Pharma Inhalation and Nasal Spray Generic Drugs Product and Services
Table 42. Beximco Pharma Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hikma (Roxane) Basic Information, Manufacturing Base and Competitors
Table 44. Hikma (Roxane) Major Business
Table 45. Hikma (Roxane) Inhalation and Nasal Spray Generic Drugs Product and Services
Table 46. Hikma (Roxane) Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. XIANJU PHARMA Basic Information, Manufacturing Base and Competitors
Table 48. XIANJU PHARMA Major Business
Table 49. XIANJU PHARMA Inhalation and Nasal Spray Generic Drugs Product and Services
Table 50. XIANJU PHARMA Inhalation and Nasal Spray Generic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Inhalation and Nasal Spray Generic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Inhalation and Nasal Spray Generic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Inhalation and Nasal Spray Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Inhalation and Nasal Spray Generic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Inhalation and Nasal Spray Generic Drugs Production Site of Key Manufacturer
Table 56. Inhalation and Nasal Spray Generic Drugs New Entrant and Capacity Expansion Plans
Table 57. Inhalation and Nasal Spray Generic Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global Inhalation and Nasal Spray Generic Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Global Inhalation and Nasal Spray Generic Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Global Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Inhalation and Nasal Spray Generic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Global Inhalation and Nasal Spray Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Global Inhalation and Nasal Spray Generic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Inhalation and Nasal Spray Generic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Inhalation and Nasal Spray Generic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Inhalation and Nasal Spray Generic Drugs Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Global Inhalation and Nasal Spray Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Global Inhalation and Nasal Spray Generic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Inhalation and Nasal Spray Generic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Inhalation and Nasal Spray Generic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Inhalation and Nasal Spray Generic Drugs Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Inhalation and Nasal Spray Generic Drugs Sales by Country (2017-2022) & (K Units)
Table 75. North America Inhalation and Nasal Spray Generic Drugs Sales by Country (2023-2028) & (K Units)
Table 76. North America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 79. North America Inhalation and Nasal Spray Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 80. North America Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 81. North America Inhalation and Nasal Spray Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Europe Inhalation and Nasal Spray Generic Drugs Sales by Country (2017-2022) & (K Units)
Table 83. Europe Inhalation and Nasal Spray Generic Drugs Sales by Country (2023-2028) & (K Units)
Table 84. Europe Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Inhalation and Nasal Spray Generic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Europe Inhalation and Nasal Spray Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Europe Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Europe Inhalation and Nasal Spray Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 98. South America Inhalation and Nasal Spray Generic Drugs Sales by Country (2017-2022) & (K Units)
Table 99. South America Inhalation and Nasal Spray Generic Drugs Sales by Country (2023-2028) & (K Units)
Table 100. South America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 103. South America Inhalation and Nasal Spray Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 104. South America Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 105. South America Inhalation and Nasal Spray Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Inhalation and Nasal Spray Generic Drugs Raw Material
Table 115. Key Manufacturers of Inhalation and Nasal Spray Generic Drugs Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Inhalation and Nasal Spray Generic Drugs Typical Distributors
Table 119. Inhalation and Nasal Spray Generic Drugs Typical Customers
List of Figures
Figure 1. Inhalation and Nasal Spray Generic Drugs Picture
Figure 2. Global Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Type in 2021
Figure 3. Corticosteroids
Figure 4. Bronchodilators
Figure 5. Combinations
Figure 6. Decongestant Sprays
Figure 7. Others
Figure 8. Global Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Application in 2021
Figure 9. Asthma
Figure 10. COPD
Figure 11. Allergic Rhinitis
Figure 12. Others
Figure 13. Global Inhalation and Nasal Spray Generic Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Inhalation and Nasal Spray Generic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Inhalation and Nasal Spray Generic Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Inhalation and Nasal Spray Generic Drugs Price (2017-2028) & (USD/Unit)
Figure 17. Global Inhalation and Nasal Spray Generic Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Inhalation and Nasal Spray Generic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Inhalation and Nasal Spray Generic Drugs Market Drivers
Figure 20. Inhalation and Nasal Spray Generic Drugs Market Restraints
Figure 21. Inhalation and Nasal Spray Generic Drugs Market Trends
Figure 22. Global Inhalation and Nasal Spray Generic Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Inhalation and Nasal Spray Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Inhalation and Nasal Spray Generic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Inhalation and Nasal Spray Generic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Inhalation and Nasal Spray Generic Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Inhalation and Nasal Spray Generic Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Inhalation and Nasal Spray Generic Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Inhalation and Nasal Spray Generic Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Inhalation and Nasal Spray Generic Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Inhalation and Nasal Spray Generic Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Inhalation and Nasal Spray Generic Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Inhalation and Nasal Spray Generic Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Inhalation and Nasal Spray Generic Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Inhalation and Nasal Spray Generic Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Inhalation and Nasal Spray Generic Drugs in 2021
Figure 81. Manufacturing Process Analysis of Inhalation and Nasal Spray Generic Drugs
Figure 82. Inhalation and Nasal Spray Generic Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の吸入＆点鼻薬ジェネリック医薬品市場2022年：コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他(Global Inhalation and Nasal Spray Generic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の吸入＆点鼻薬ジェネリック医薬品市場2022年：コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp